Results 11 to 20 of about 10,603,245 (304)

D-dimer testing: A narrative review

open access: yes, 2023
D-dimer containing species are soluble fibrin degradation products derived from plasmin-mediated degradation of cross-linked fibrin, i.e., 'D-dimer'. D-dimer can hence be considered a biomarker of in vivo activation of both coagulation and fibrinolysis, the leading clinical application in daily practice of which is ruling out venous thromboembolism ...
Wauthier, L.   +11 more
openaire   +6 more sources

D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis [PDF]

open access: yesThrombosis Journal, 2021
Background Data on the prognostic role of D-dimer in patients with acute coronary syndrome (ACS) are controversial. Our aim was to summarize current evidence on the association between D-dimer levels and short/long-term poor prognosis of ACS patients. We
Flavio Giuseppe Biccirè   +5 more
doaj   +2 more sources

Performance of age-adjusted D-dimer values for predicting DVT before the knee and hip arthroplasty

open access: yesJournal of Orthopaedic Surgery and Research, 2021
Purpose To compare the specificity and sensitivity of preoperative D-dimer and age-adjusted D-dimer value for predicting the incidence of the DVT preoperatively in total joint arthroplasty (TJA) patients. Methods We enrolled 406 patients finally above 50 
Jian Xiang Wu   +4 more
doaj   +1 more source

D-Dimer as a Prognostic Factor in a Tertiary Center Intensive Coronary Care Unit

open access: yesClinical and Applied Thrombosis/Hemostasis, 2022
Introduction D-dimer is a small protein fragment produced during fibrinolysis. High D-dimer levels were shown to have prognostic impact in critically ill patients.
Moshe Rav Acha MD   +15 more
doaj   +1 more source

Association between D-dimer level and chest CT severity score in patients with SARS-COV-2 pneumonia

open access: yesScientific Reports, 2021
The elevated level of D-dimer and its relationship with poor outcomes in SARS-COV-2 pneumonia patients have been demonstrated. In addition to a hypercoagulable state, D-dimer is also a biomarker of inflammation. We investigated the relationship between D-
Lan Wang   +4 more
doaj   +1 more source

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundCoronary microvascular dysfunction (CMVD), an important etiology of ischemic heart disease, has been widely studied. D-dimer is a simple indicator of microthrombosis and inflammation.
Yan Lin   +11 more
doaj   +1 more source

D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China

open access: yesFrontiers in Pharmacology, 2020
Background: D-dimer is a small protein fragment and high levels of D-dimer have been associated with increased mortality in patients presenting to emergency departments with infection.
Jinpeng Li   +10 more
doaj   +1 more source

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.

open access: yesPLoS ONE, 2021
IntroductionCoronavirus Disease 2019 is a primarily respiratory illness that can cause thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in COVID-19, though optimal cutoff value for D-dimer to predict mortality has ...
Ayusha Poudel   +7 more
doaj   +1 more source

Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study. [PDF]

open access: yesPLoS ONE, 2016
D-dimer level in cancer patients is associated with risk of venous thromboembolism and deep venous thrombosis. Most cancer patients have "abnormal" D-dimer levels based on the current normal reference range.
Jing Yu   +12 more
doaj   +1 more source

Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism [PDF]

open access: yes, 2021
Background D-dimer, a global biomarker for activation of the coagulation and fibrinolysis systems, is useful in assessing individual risk of venous thromboembolism (VTE) recurrence.
Hansen, John Bjarne   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy